Ischemic Stroke Impairs Coronary Microvascular Function via Circulating EVs and RGD-Motif Endothelin Signaling
Background
Patients recovering from ischemic stroke face a heightened risk of subsequent cardiac events, yet the precise mechanisms linking cerebral ischemia to coronary microvascular dysfunction (CMD) remain poorly understood. Current understanding points to systemic factors, but the specific mediators and pathways are unclear. This gap in knowledge limits targeted therapeutic strategies to mitigate post-stroke cardiac complications. This research investigates circulating factors, specifically extracellular vesicles (EVs), and their role in mediating a brain-heart vascular axis that impairs coronary function, focusing on endothelin signaling as a key pathway.
Study Design
Researchers investigated coronary microvascular function in patients with prior ischemic stroke and in a rat model of transient middle cerebral artery occlusion (MCAO). They assessed vasodilator function of coronary arterioles (CA) in both human and rat subjects. To identify mediating factors, extracellular vesicles (EVs) were isolated from rats after cerebral ischemia. These EVs were then delivered into the rat CA lumen to observe their direct impact on vasodilation. Furthermore, the study explored the role of specific peptide motifs by luminally delivering RGD peptide into rat CA, and tested the effect of BQ-123, an endothelin ETA receptor antagonist, on RGD peptide-induced effects.
Results
The study revealed that vasodilator function of coronary arterioles was significantly reduced in patients with prior ischemic stroke. Similarly, in the rat model, transient middle cerebral artery occlusion consistently impaired CA vasodilator function. This dysfunction was directly recapitulated when extracellular vesicles (EVs) isolated from post-ischemic brains were delivered into the rat CA lumen, demonstrating their capacity to impair vasodilation. A key mechanistic insight emerged from the peptide experiments: > Luminal delivery of RGD peptide attenuated flow-induced vasodilation in rat CA, an effect that was completely prevented by BQ-123, a specific endothelin ETA receptor antagonist. This strongly suggests that ischemic stroke induces coronary microvascular dysfunction through circulating EV-mediated, RGD-motif-dependent activation of endothelin signaling, establishing a novel brain-heart vascular axis. These findings provide a concrete mechanistic basis for the observed increase in post-stroke coronary risk.
Key Findings
- Coronary arteriole vasodilator function was reduced in patients with prior ischemic stroke.
- Transient middle cerebral artery occlusion in rats impaired coronary arteriole vasodilator function.
- Extracellular vesicles (EVs) from ischemic brains directly impaired rat coronary arteriole vasodilation.
- Luminal RGD peptide attenuated flow-induced vasodilation in rat coronary arterioles.
- The effect of RGD peptide was prevented by BQ-123, an endothelin
ETA receptorantagonist.
Why It Matters
This research identifies a critical brain-heart vascular axis where ischemic stroke directly impairs coronary microvascular function via circulating extracellular vesicles and RGD-motif-dependent endothelin signaling. For clinicians and biohackers, this means that post-stroke cardiac risk isn't just a comorbidity but a direct consequence mediated by specific circulating factors. Targeting EV-mediated pathways or endothelin ETA receptors could offer novel therapeutic strategies to prevent or mitigate cardiac complications after stroke. While BQ-123 was used experimentally, its ability to block RGD peptide effects suggests that existing or novel ETA receptor antagonists could be explored. This shifts the paradigm from treating symptoms to addressing the underlying systemic communication between the brain and heart post-stroke, potentially leading to new protocols for cardiac protection.
ischemic stroke
coronary microvascular dysfunction
extracellular vesicles
rgd peptide
endothelin signaling
eta receptor